|
Summary Information: IMARA Inc. Common Stock NASDAQ:IMRA |
admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Imara Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. Imara is currently advancing IMR-687, a highly selective, potent small molecule inhibitor of PDE9 that is an oral, once-a-day, potentially disease-modifying treatment for sickle cell disease and beta-thalassemia.
__The following are links to various summary and news pages for __IMARA Inc. Common Stock [ IMRA ]. __Note: Some Links might not have information for the company. |
|